PineBridge Investments’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-73,157
| Closed | -$1.42M | – | 1178 |
|
|
2018
Q1 | $1.42M | Sell |
73,157
-51,355
| -41% | -$1.01M | 0.03% | 493 |
|
|
2017
Q4 | $2.07M | Buy |
124,512
+14,297
| +13% | +$262K | 0.05% | 344 |
|
|
2017
Q3 | $2.24M | Sell |
110,215
-5,345
| -5% | -$102K | 0.05% | 280 |
|
|
2017
Q2 | $1.86M | Buy |
115,560
+105,940
| +1,101% | +$1.57M | 0.05% | 296 |
|
|
2017
Q1 | $121K | Buy |
9,620
+229
| +2% | +$2.77K | ﹤0.01% | 889 |
|
|
2016
Q4 | $125K | Hold |
9,391
| – | – | ﹤0.01% | 940 |
|
|
2016
Q3 | $223K | Buy |
9,391
+592
| +7% | +$15.9K | 0.01% | 479 |
|
|
2016
Q2 | $253K | Buy |
8,799
+460
| +6% | +$15K | 0.01% | 419 |
|
|
2016
Q1 | $267K | Sell |
8,339
-558
| -6% | -$19.6K | 0.01% | 388 |
|
|
2015
Q4 | $381K | Buy |
8,897
+390
| +5% | +$15.6K | 0.02% | 347 |
|
|
2015
Q3 | $299K | Buy |
8,507
+801
| +10% | +$36.1K | 0.01% | 404 |
|
|
2015
Q2 | $354K | Sell |
7,706
-9,342
| -55% | -$443K | 0.01% | 362 |
|
|
2015
Q1 | $799K | Buy |
17,048
+2,041
| +14% | +$81.2K | 0.03% | 306 |
|
|
2014
Q4 | $475K | Buy |
15,007
+859
| +6% | +$25.1K | 0.02% | 412 |
|
|
2014
Q3 | $335K | Buy |
14,148
+3,959
| +39% | +$101K | 0.01% | 472 |
|
|
2014
Q2 | $305K | Sell |
10,189
-5,997
| -37% | -$162K | 0.01% | 431 |
|
|
2014
Q1 | $427K | Sell |
16,186
-1,562
| -9% | -$39K | 0.01% | 479 |
|
|
2013
Q4 | $447K | Buy |
17,748
+10,448
| +143% | +$233K | 0.01% | 510 |
|
|
2013
Q3 | $150K | Sell |
7,300
-45
| -0.6% | -$929 | ﹤0.01% | 590 |
|
|
2013
Q2 | $146K | Buy |
+7,345
| New | +$130K | ﹤0.01% | 578 |
|
PineBridge Investments's IPXL Position: Q2 2018 in Review
PineBridge Investments sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 73,157 shares — an estimated $1.42M sold.
PineBridge Investments first reported a position in IPXL in Q2 2013 and held it in 20 quarters. The position peaked at $2.24M in Q3 2017. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.
- PineBridge Investments reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
- PineBridge Investments sold 73,157 Impax Laboratories, Inc. shares in Q2 2018, an estimated $1.42M.
- PineBridge Investments first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 20 quarters.
- PineBridge Investments's Impax Laboratories, Inc. position peaked at $2.24M in Q3 2017.
- 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.
Based on PineBridge Investments's 13F filing for Q2 2018, filed 9 Aug 2018.